Hyperinsulinism — Novel Genes, Drugs and Guidelines
Skip to content
This two-day international symposium will review exciting developments in the field of hyperinsulinism, including novel genetic causes, new care guidelines and promising investigational therapies. The symposium is intended to enhance the knowledge and practice of endocrinologists, neonatologists, surgeons, pathologists, radiologists, geneticists and nurses as well as basic scientists interested in islet cell biology. The symposium faculty, leaders in the field of hyperinsulinism, will present over 20 plenary lectures on the biology, genetics and clinical aspects of hyperinsulinism. Participants will have the opportunity to engage with the faculty through several expert panels and breakout sessions.
View the latest information about the two-day international symposium.